MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update ...Middle East

SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that the Phase 1b trial arm exploring zandelisib, an investigational selective phosphatidylinositol 3-kinase ("PI3K")...

Hence then, the article about mei pharma announces expansion of phase 1b study evaluating zandelisib and clinical pipeline update was published today ( Monday 04/01/2021 - 03:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update )

Also on site :

• Legally Blonde Prequel Series Elle Is 'Officially Canon' With The Movie, EPs Confirm — Here's How They Made Sure 'Everything Tracked'
• SEC recruiting update: Every team’s ranking entering July
• Iran raises the stakes – no negotiations without these conditions